Education
About Us
Working with TipRanks
Follow Us
Peter Graham Insider Profile
4 Followers
Peter Graham, Senior Officer at Dechra Pharmaceuticals, holds 55.30K shares in Dechra Pharmaceuticals (Ticker: GB:DPH). Most recently, Peter Graham ― shares of Dechra Pharmaceuticals on ― for an estimated value of ―.
Peter Graham Dechra Pharmaceuticals (DPH)Senior Officer
Dechra Pharmaceuticals (DPH)
Senior Officer
Not Ranked
Peter Graham has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Peter Graham does not currently own shares as a corporate insider.
A breakdown of Peter Graham's holdings
Insider Roles
Peter Graham does not currently hold a role as a corporate insider.
Roles that Peter Graham holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Peter Graham
Peter Graham's Trading History
List of latest transactions for each holding click on a transaction to see Peter Graham's performance on stock
You May Also Like
Peter Graham insider profile FAQ
What is the percentage of profitable transactions made by Peter Graham?
The percentage of profitable transactions made by Peter Graham is ―.
What is the average return per transaction made by Peter Graham?
The average return per transaction made by Peter Graham is ―.
What stocks does Peter Graham hold?
Peter Graham holds: GB:DPH stocks.
What was Peter Graham’s latest transaction?
Peter Graham latest transaction was an Uninformative Buy of ―.
What was Peter Graham's most profitable transaction?
Peter Graham’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Peter Graham's role in Dechra Pharmaceuticals?
Peter Graham's role in Dechra Pharmaceuticals is Senior Officer.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.